PRIMARY STUDY
A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
Key Findings: In this single case study physicians report the experience of a 14 year old patient with autism symptoms including selective mutism, anxiety, and controlled epilepsy who responded very well (i.e. positive effects on behavioral symptoms and core social deficits) to a very low dose CBD extract.
Type of Study: Meta-analysis
Study Sample Size: 1
Study Result: Positive
Study Location(s): Canada
Year of Pub: 2020
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source: Cannabis Flower derived
Chemotype: Chemotype III
Sub-Ratio: 1:20 (THC:CBD)
Dosage: 1:20 (THC CBD) in an olive oil carrier (from CanniMed). His parents were instructed to administer 0.1 mL twice a day (2 mg CBD and 0.1 mg THC) and increase by 0.1 mL (2 mg CBD and 0.1 mg THC) per dose if no effects were shown to a maximum of 0.5 mL (10 mg CBD and 0.5 mg THC) per dose.
Route of Administration: Oral (Ingestion)
Link to study
